...
【24h】

Pharmacologic management of osteoporosis

机译:骨质疏松症的药理管理

获取原文
获取原文并翻译 | 示例
           

摘要

Osteoporosis is a serious health problem of endemic proportions in the United States. Approximately 50% of women will experience an osteoporosis-related fracture during their lifetimes. With the increase in the population of women age 65 and older, nurses need to be familiar with osteoporosis risks, prevention strategies, and screening guidelines to promote well-woman care. We provide an overview of the medications approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis.
机译:在美国,骨质疏松是严重的地方性健康问题。大约50%的女性一生中会经历与骨质疏松症相关的骨折。随着65岁及65岁以上女性人口的增加,护士需要熟悉骨质疏松症的风险,预防策略和筛查指南,以促进对女性的护理。我们提供了由美国食品药品监督管理局(FDA)批准用于治疗和预防骨质疏松症的药物的概述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号